Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:34 pm Purchase | 13G | TC BIOPHARM HLDGS PLC SPONSORE TCBP | ARMISTICE CAPITAL LLC | 105,938 9.99% | 105,938 (New Position) | View |
| 2024-01-29 09:16 am Sale | 13G | TC BIOPHARM HLDGS PLC SPONSORE TCBP | MEDINET Co. Ltd. | 0 0% | -73,500 (Position Closed) | View |
| 2023-02-28 4:39 pm Purchase | 13G | TC BIOPHARM HLDGS PLC SPONSORE TCBP | Nipro Corp | 38,610 4% | 38,610 (New Position) | View |
| 2023-02-14 1:35 pm Purchase | 13G | TC BIOPHARM HLDGS PLC SPONSORE TCBP | ARMISTICE CAPITAL LLC | 96,253 9.99% | 96,253 (New Position) | View |
| 2023-01-30 09:50 am Purchase | 13G | TC BIOPHARM HLDGS PLC SPONSORE TCBP | MEDINET Co. Ltd. | 73,500 7.7% | 73,500 (New Position) | View |
| 2023-01-11 2:35 pm Sale | 13D | TC BIOPHARM HLDGS PLC SPONSORE TCBP | Renaissance Capital Partners Ltd | 392,915 33% | -8,752,882 (-95.70%) | View |
| 2022-04-27 3:53 pm Purchase | 13D | TC BIOPHARM HLDGS PLC SPONSORE TCBP | Renaissance Capital Partners Ltd | 9,145,797 27% | 9,145,797 (New Position) | View |
| 2022-03-17 4:49 pm Purchase | 13G | TC BIOPHARM HLDGS PLC SPONSORE TCBP | Alta Partners LLC | 2,925,164 9.7% | 2,925,164 (New Position) | View |
| 2022-02-22 06:05 am Purchase | 13D | TC BIOPHARM HLDGS PLC SPONSORE TCBP | Scottish Enterprise | 4,432,683 15.79% | 4,432,683 (New Position) | View |